These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

209 related articles for article (PubMed ID: 27242790)

  • 1. Modulation of Chemokine Responses: Synergy and Cooperativity.
    Proudfoot AE; Uguccioni M
    Front Immunol; 2016; 7():183. PubMed ID: 27242790
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Chemokine interaction with synergy-inducing molecules: fine tuning modulation of cell trafficking.
    Cecchinato V; D'Agostino G; Raeli L; Uguccioni M
    J Leukoc Biol; 2016 Jun; 99(6):851-5. PubMed ID: 26715684
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Chemokines and other GPCR ligands synergize in receptor-mediated migration of monocyte-derived immature and mature dendritic cells.
    Gouwy M; Struyf S; Leutenez L; Pörtner N; Sozzani S; Van Damme J
    Immunobiology; 2014 Mar; 219(3):218-29. PubMed ID: 24268109
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Glycosaminoglycan Interactions with Chemokines Add Complexity to a Complex System.
    Proudfoot AEI; Johnson Z; Bonvin P; Handel TM
    Pharmaceuticals (Basel); 2017 Aug; 10(3):. PubMed ID: 28792472
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Chemokine receptor oligomerization: a further step toward chemokine function.
    Muñoz LM; Holgado BL; Martínez-A C; Rodríguez-Frade JM; Mellado M
    Immunol Lett; 2012 Jul; 145(1-2):23-9. PubMed ID: 22698180
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Targeting Chemokine-Glycosaminoglycan Interactions to Inhibit Inflammation.
    Crijns H; Vanheule V; Proost P
    Front Immunol; 2020; 11():483. PubMed ID: 32296423
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Chemokine cooperativity is caused by competitive glycosaminoglycan binding.
    Verkaar F; van Offenbeek J; van der Lee MMC; van Lith LHCJ; Watts AO; Rops ALWMM; Aguilar DC; Ziarek JJ; van der Vlag J; Handel TM; Volkman BF; Proudfoot AEI; Vischer HF; Zaman GJR; Smit MJ
    J Immunol; 2014 Apr; 192(8):3908-3914. PubMed ID: 24639348
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Relationships between glycosaminoglycan and receptor binding sites in chemokines-the CXCL12 example.
    Laguri C; Arenzana-Seisdedos F; Lortat-Jacob H
    Carbohydr Res; 2008 Aug; 343(12):2018-23. PubMed ID: 18334249
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Overview of the mechanisms regulating chemokine activity and availability.
    Mortier A; Van Damme J; Proost P
    Immunol Lett; 2012 Jul; 145(1-2):2-9. PubMed ID: 22698177
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Glycosaminoglycan binding and oligomerization are essential for the in vivo activity of certain chemokines.
    Proudfoot AE; Handel TM; Johnson Z; Lau EK; LiWang P; Clark-Lewis I; Borlat F; Wells TN; Kosco-Vilbois MH
    Proc Natl Acad Sci U S A; 2003 Feb; 100(4):1885-90. PubMed ID: 12571364
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Synergy between proinflammatory ligands of G protein-coupled receptors in neutrophil activation and migration.
    Gouwy M; Struyf S; Catusse J; Proost P; Van Damme J
    J Leukoc Biol; 2004 Jul; 76(1):185-94. PubMed ID: 15075362
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Chemokine Heteromers and Their Impact on Cellular Function-A Conceptual Framework.
    Blanchet X; Weber C; von Hundelshausen P
    Int J Mol Sci; 2023 Jun; 24(13):. PubMed ID: 37446102
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Chemokine Heterocomplexes and Cancer: A Novel Chapter to Be Written in Tumor Immunity.
    D'Agostino G; Cecchinato V; Uguccioni M
    Front Immunol; 2018; 9():2185. PubMed ID: 30319638
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Regulation of Chemokine Activity - A Focus on the Role of Dipeptidyl Peptidase IV/CD26.
    Metzemaekers M; Van Damme J; Mortier A; Proost P
    Front Immunol; 2016; 7():483. PubMed ID: 27891127
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Glycosaminoglycans mediate cell surface oligomerization of chemokines.
    Hoogewerf AJ; Kuschert GS; Proudfoot AE; Borlat F; Clark-Lewis I; Power CA; Wells TN
    Biochemistry; 1997 Nov; 36(44):13570-8. PubMed ID: 9354625
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Synergy-inducing chemokines enhance CCR2 ligand activities on monocytes.
    Kuscher K; Danelon G; Paoletti S; Stefano L; Schiraldi M; Petkovic V; Locati M; Gerber BO; Uguccioni M
    Eur J Immunol; 2009 Apr; 39(4):1118-28. PubMed ID: 19291700
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Designing a mutant CCL2-HSA chimera with high glycosaminoglycan-binding affinity and selectivity.
    Gerlza T; Winkler S; Atlic A; Zankl C; Konya V; Kitic N; Strutzmann E; Knebl K; Adage T; Heinemann A; Weis R; Kungl AJ
    Protein Eng Des Sel; 2015 Aug; 28(8):231-40. PubMed ID: 25969511
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The biological relevance of chemokine-proteoglycan interactions.
    Proudfoot AE
    Biochem Soc Trans; 2006 Jun; 34(Pt 3):422-6. PubMed ID: 16709177
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Chemokine receptor oligomerization: functional considerations.
    Thelen M; Muñoz LM; Rodríguez-Frade JM; Mellado M
    Curr Opin Pharmacol; 2010 Feb; 10(1):38-43. PubMed ID: 19828377
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Basic chemokine-derived glycosaminoglycan binding peptides exert antiviral properties against dengue virus serotype 2, herpes simplex virus-1 and respiratory syncytial virus.
    Vanheule V; Vervaeke P; Mortier A; Noppen S; Gouwy M; Snoeck R; Andrei G; Van Damme J; Liekens S; Proost P
    Biochem Pharmacol; 2016 Jan; 100():73-85. PubMed ID: 26551597
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.